SGX Market Information
SGX My Gateway Market Updates
Recent Market Rebound Extended to SGX Value Stocks
29 December 2020
4 of the STI’s 10 strongest performers in the 4Q-to-date ranked highly for the Value factors in early 2H20. These 4 stocks were Jardine Matheson, Sembcorp Industries, Jardine Strategic and CapitaLand. UOL Group and Yangzijiang Shipbuilding also ranked highly for the Value factor.
GHY Culture & Media – Entertainment & Content Producer in APAC – Lists on SGX
18 December 2020
GHY Culture & Media, an entertainment business that focuses on the production and promotion of dramas, films and concerts in the APAC region, made its debut on the SGX Mainboard.
Medtecs Led Most Traded SGX Catalist Stocks in 2020
15 December 2020
Combined, the 10 most traded Catalist stocks in the 2020 year-to-14 Dec have seen more than S$50 million in turnover a day and include as many as five healthcare-related stocks – Medtecs International, UG Healthcare, Biolidics, Clearbridge Health and Hyphens Pharma.
Credit Bureau Asia – SEA’s Leading Credit & Risk Information Solutions Provider – Lists on SGX
03 December 2020
Credit Bureau Asia, the largest provider of credit bureau services within Singapore and the sole credit bureau in Cambodia and Myanmar, made its debut on the SGX Mainboard.
STI Posts Strongest Month of Gains Since May 2009
01 December 2020
With a 15.8% price gain and 16.2% total return in the month of November 2020, this was the strongest month of gains for the Straits Times Index (STI) since May 2009. DBS, OCBC and UOB which make up approximately 40% of the STI averaged 21% total returns with net institutional inflows of S$1.5 billion.
STI Investing Reaches S$2 Billion Milestone
26 November 2020
The AUM of the 2 ETFs that track the STI - SPDR® STI ETF and Nikko AM STI ETF took 17 years to reach the S$1 billion milestone in June 2019, and just 17 months to further reach the S$2 billion threshold.
STI's 2019 Reserve List More Defensive than STI in 2020
25 November 2020
Investing in the STI Reserve List as it stood at the end of 2019, with equal weightage to the 5 stocks has so far generated a 2% decline in total return in 2020, compared to the STI’s decline of 7%.
SGX Transportation Stocks On The Move With 11% Gains In Early November
17 November 2020
Singapore’s 10 most traded transport-related stocks gain 11% in the November month-to-date, in-line with the gains of the top quartile of global transportation stocks by market value. SATS has been the strongest gainer of the 10 Singapore stocks. The most defensive of the 10 stocks in the 2020 year-to-date was Catalist-listed GKE Corporation.
US Presidential Election Fuels Rally in Singapore Stocks
09 November 2020
While the developments in US Election buoyed stocks across the region last week, the STI was one of just two Asia Pacific stock benchmarks that rallied above 6.0% over the five sessions, with the other benchmark South Korea’s KOSPI.
FTSE ST Consumer Goods & Services Index’s 3 Largest F&B Producers
04 November 2020
Of the 10 largest constituents in the FTSE ST Consumer Goods & Services Index, the 3 largest food and/or beverage producers are Wilmar International, Thai Beverage and Golden Agri-Resources.
These articles are provided by SGX My Gateway.
SGX My Gateway
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.